Vor Biopharma VOR Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $17.6M-34.1% | $19.19M-24.3% | $14.14M-35.2% | $261.5M+1,098% | $26.7M+9.8% | ||
| $17.57M+167% | $16.77M+181% | $13.97M+109% | $12.79M+77.3% | $6.59M-17.7% | ||
| $35.16M+5.6% | $35.96M+14.8% | $28.11M-1.4% | $274.28M+845% | $33.29M+3.0% | ||
| $35.16M+5.6% | $35.96M+14.8% | $28.11M-1.4% | $274.28M+845% | $33.29M+3.0% | ||
| -$35.16M-5.6% | -$35.96M-14.8% | -$28.11M+1.4% | -$274.28M-845% | -$33.29M-3.0% | ||
| $3.94M+389% | $2.8M+367% | $1.73M+81.4% | $537K-55.1% | $805K-47.1% | ||
| -$184.43M-23,010% | —— | -$784.58M-82,341% | -$1.3B-108,744% | $805K-47.1% | ||
| -$219.59M-576% | —— | -$812.68M-2,849% | -$1.57B-5,553% | -$32.49M-5.5% | ||
| -$5.11+1.9% | —— | -$121.63-1,411% | -$12.56-2,963% | -$5.21-1,058% | ||
| -$5.11+1.9% | —— | -$121.63-1,411% | -$12.56-2,963% | -$5.21-1,058% | ||
| 43M+589% | 9.9M+187% | 6.7M+95.2% | 125.3M+83.4% | 6.2M-90.8% | ||
| 43M+589% | 9.9M+187% | 6.7M+95.2% | 125.3M+83.4% | 6.2M-90.8% | ||
| -$220.33M-578% | —— | -$812.69M-2,864% | -$1.57B-5,556% | -$32.49M-5.4% | ||
| -$747K-74,800% | $29K— | -$2K-101% | -$9K-153% | $1K+110% | ||
| —— | $2K— | $4.15M— | —— | —— | ||
| -$35.16M-5.6% | -$35.96M-14.8% | -$28.11M+1.4% | -$274.28M-845% | -$33.29M-3.0% | ||
| -$35.13M-8.2% | -$35.94M-18.0% | -$28.11M-1.8% | -$272.18M-867% | -$32.47M-3.5% | ||
| -$35.13M-8.2% | -$35.94M-18.0% | -$28.11M-1.8% | -$272.18M-867% | -$32.47M-3.5% | ||
| -$35.16M-5.6% | -$35.96M-14.8% | -$28.11M+1.4% | -$274.28M-845% | -$33.29M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Vor Biopharma profitable?
- Vor Biopharma is not currently profitable: it reported a net loss of $2.6B over the trailing twelve months.
- What is Vor Biopharma's earnings per share?
- Vor Biopharma's diluted EPS over the trailing twelve months is $-144.51.
- Where does Vor Biopharma's income statement data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.